| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968991 | Vaccine | 2011 | 6 Pages |
Abstract
Cellular immunity to influenza vaccination in RTX-treated patients was similar to DMARDs-treated patients and healthy controls, while humoral immunity was severely impaired. The preservation of cellular immunity may explain the relatively low rate of infection among B-cell depleted patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
U. Arad, S. Tzadok, S. Amir, M. Mandelboim, E. Mendelson, I. Wigler, H. Sarbagil-Maman, D. Paran, D. Caspi, O. Elkayam,